Document Detail

Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance.
MedLine Citation:
PMID:  24760989     Owner:  NLM     Status:  Publisher    
Using a novel positron emission tomography (PET) method with oral administration of 14(R,S)-[(18)F]-fluoro-6-thia-heptadecanoic acid ((18)FTHA), we recently demonstrated that subjects with impaired glucose tolerance (IGT) display an impairment in cardiac function associated with increased myocardial uptake of dietary fatty acids. Here, we determined whether modest weight loss induced by lifestyle changes might improve these cardiac metabolic and functional abnormalities. Nine participants with IGT, enrolled in a one-year lifestyle intervention trial, were invited to undergo determination of organ-specific postprandial dietary fatty acids partition using the oral (18)FTHA method, and cardiac function and oxidative metabolic index using PET 11C-acetate kinetics with ECG-gated PET ventriculography prior to and after the intervention. The intervention resulted in significant weight loss and reduction of waist circumference, without significant change in postprandial plasma glucose, insulin, nonesterified fatty acid or triglyceride levels. We observed a significant increase in stroke volume, cardiac output and left ventricular ejection fraction associated with reduced myocardial oxidative metabolic index and fractional dietary fatty acid uptake. Modest weight loss corrects the exaggerated myocardial channelling of dietary fatty acids and improves myocardial energy substrate metabolism and function in IGT subjects ( NCT 00969007).
Sébastien M Labbé; Christophe Noll; Thomas Grenier-Larouche; Margaret Kunach; Lucie Bouffard; Serge Phoenix; Brigitte Guérin; Jean-Patrice Baillargeon; Marie-France Langlois; Eric E Turcotte; Andre C Carpentier
Related Documents :
4053389 - Benzoylalanine: detection and identification of an alanine conjugate with benzoic acid ...
1006719 - Isolation and identification of a sulfur-containing metabolite of spironolactone from h...
3260239 - Direct and simultaneous high-performance liquid chromatographic assay for the determina...
19795109 - Determination of butoxyacetic acid (biomarker of ethylene glycol monobutyl ether exposu...
2420959 - An investigation of demethylation in the metabolism of methoxytryptamine and methoxytry...
15639459 - Determination of total phthalates in urine by isotope-dilution liquid chromatography-ta...
19202309 - The volatile constituents of the flower, leaf, and stem of verbascum wiedemannianum gro...
8082729 - A beta 2rare-lacz transgene identifies retinoic acid-mediated transcriptional activatio...
24898239 - Achieving optimal n-3 fatty acid status: the vegetarian's challenge . . . or not.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-4-22
Journal Detail:
Title:  American journal of physiology. Endocrinology and metabolism     Volume:  -     ISSN:  1522-1555     ISO Abbreviation:  Am. J. Physiol. Endocrinol. Metab.     Publication Date:  2014 Apr 
Date Detail:
Created Date:  2014-4-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100901226     Medline TA:  Am J Physiol Endocrinol Metab     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Next Document:  Augmented expression and secretion of adipose derived PEDF does not alter local angiogenesis or cont...